Celogics
Celogics develops high-quality human induced pluripotent stem cell (iPSC) products for drug discovery and safety screening. The company specializes in engineered, functional iPSC-derived cardiomyocytes that maintain robust electrophysiological integrity across 2D, 3D, and organoid systems. These reproducible cell models accelerate disease modeling and therapeutic research by providing physiologically relevant data.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Celogics develops high-quality human induced pluripotent stem cell (iPSC) products for drug discovery and safety screening. The company specializes in engineered, functional iPSC-derived cardiomyocytes that maintain robust electrophysiological integrity across 2D, 3D, and organoid systems. These reproducible cell models accelerate disease modeling and therapeutic research by providing physiologically relevant data.